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Background: In the last years Italy is confronting with massive migratory movements from developing countries
where hemoglobinopathies are widespread. This is causing a large diffusion and a changing spectrum in the
epidemiology of hemoglobin disorders in Italy.
Methods: Investigations recently published in Italy on hemoglobinopathies among immigrants were revised in
order to appreciate the impact of immigration from developing countries on epidemiology of these pathologies
and to outline adequate guidelines of prevention.
Results: Although in Italy there is a limited number of investigations regarding the relation between immigration
and hemoglobin disorders, published data show that in our Nation there is a changing and increasing spectrum of
hemoglobinopathies linked to immigration.
Conclusions: Prospective and retrospective actions of public healthy preventive policy are requested, based upon
information (health educational programs for immigrants and caregivers), screenings among immigrants (school
screening, pre-marital, preconception and early pregnancy screening, newborn screening), counseling for foreign
at-risk couples and healthy carriers.
Keywords: Immigration, HemoglobinopathiesThe inherited disorders of hemoglobinopathies are among
the most common monogenic diseases in the world, and
about 4,5 % of all human beings carry a gene for these
abnormalities [1,2]. Sickle Cell Disease (SCD) is by far the
most common and is mainly widespread in Sub-Saharan
Africa, Middle-East, India and in people of African ances-
try living in Europe, North, Central and South America
[3,4] . Thalassemias and hemoglobin E (HbE) are the sec-
ond most common, occurring at a high frequency in
Mediterranean area, Middle East, Central Asia, Indian
Subcontinent, Southern China (β thalassemia) and in
Middle East, Indian Sub Continent, South East Asia and
parts of Mediterranean region (α thalassemia and HbE)
[5,6]. Other less widespread anomalous hemoglobins are
hemoglobin C (HbC) that is particularly common inCorrespondence: cesco.cataldo1@libero.it
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reproduction in any medium, provided the orWest-Africa, and hemoglobin D (HbD) more frequent in
South East Asia, Middle-East and Indian Sub Continent
[4].Compound hemoglobins, (e.g. HbS/βthal, HbC/βthal,
αThal/HbE, βThal/HbE, etc.) are relatively common, while
other hemoglobinic anomalies clinically relevant are rare
around the world [4]. It is believed that carriers of some
hemoglobinopathies (α and β thalassemias, SCD, HbE)
have a selective advantage in areas where malaria was
endemic and that natural selection is responsible for ele-
vating their gene frequencies [5,6].
Although hemoglobinopathies were rare in industria-
lized Northern and Central European countries, recently
they have become much more common in these regions
through the immigration from endemic areas [7-13]. So
like during the first decades of the last century in North
America thalassemia was firstly described in immigrant
families from Southern Italy [14], recently Modell and
co-workers [7] calculated that today in Europe more
affected children are born in non historically endemicThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Cataldo Italian Journal of Pediatrics 2012, 38:32 Page 2 of 5
http://www.ijponline.net/content/38/1/32Northern and Central Nations than in Southern Euro-
pean Nations, due to migration [15,16]. Further, these
rising frequencies of hemoglobinopathies in developed
countries will likely increase in the next decades. Firstly
because the immigration’s waves from poor regions of
the world cannot be stopped and secondly because im-
migrant people are young and tend to get married in
their same ethnic group and to have a high birth-rate,
with a founder effect. In addition, immigrants have often
consanguineous marriages which increase the frequency
of all the Mendelian recessive disorders, and the major-
ity of children affected by hemoglobinopathies in
developed countries survive into adulthood because can
receive optimal medical care. Therefore, nowadays
hemoglobin disorders represent a significant health pub-
lic health problem also in developing countries where
precocious diagnosis of carriers or of affected individuals
is crucial to enable the most appropriate actions of pre-
vention and care.
Italy is historically a natural reservoir of hemoglobino-
pathies, especially β thalassemia and SCD, and more
rarely also of HbC [2,9]. Nevertheless, in the last twenty
years [17] there has been a rapid and progressive in-
crease of immigration from developing countries where
hemoglobinopathies are more frequent, particularly from
Mediterranean area, Indian Sub-Continent and South-
East Asia. Therefore, it should be considered that this
immigration wave is likely to rise the frequency of
hemoglobin variants in Italy. In our Nation we still have
not an exact knowledge of both pathological hemoglo-
bin’s carriers and hemoglobinopathies among immi-
grants, as well as of their epidemiological impact on the
general resident population. Indeed, differently to other
developed countries place of immigration [8,10-
13,16,18,19], there are only few and limited investiga-
tions regarding this changing spectrum influenced by
immigration. So, Garofalo and co-workers. [20]in Torino
observed among 254 patients diagnosed between 1994
and 1998 as having hemoglobinopathies 13 immigrants
(5.1 %), all Africans (10 with SCD and 3 with β thalas-
semia) and Furbetta and co-workers [21] among 962
residents in Umbria screened between 1987 and 1996
for hemoglobinopathies found 29 immigrants (3 %),
mainly Africans (20 HbS, 4 βthal,2 HbA2 Babinga, 1
HbC and 2 Indians (HbE). According to these data,
Russo-Mancuso and co-workers [22] in a clinical-
epidemiological survey on SCD performed during 1998
in Italian pediatric and hematological Centers found 696
residents with this anomalous hemoglobin. 44 of them
(6.3 %) had one or both foreign parents, mainly from
Africa. Remarkably, these authors noted that HbS in the
first years of their investigation had spread from Sicily
and South Italy over all the Nation as a result of a do-
mestic migration, whereas only in the last yearsimmigration, mainly from Africa, had contributed to its
large diffusion in our Nation.
Nevertheless, until a few years ago, there were not ac-
curate studies regarding the impact of immigration from
developing countries on epidemiology of hemoglobino-
pathies in Italy. Firstly Colombatti and co-workers [23]
referred the pattern of hospitalization of patients
aged< 15 years for SCD from 2000 to 2008 in the Ven-
eto Region (North East Italy).They observed 135 SCD
patients. 95 % of them were immigrants who were born
abroad or in Italy from foreign parents, and their origin
was mainly (more than 90 %) from Africa. A progressive
increase in the number of inpatient admissions was
observed in the studied period (55 in 2000, 94 in 2008).
Successively (from January 2006 to May 2009) Lippi and
co-workers [24]underwent a screening on 806 residents
in Verona (Veneto Region) before marriage (432 Cauca-
sians, 296 Africans and 78 Asian). 33/806 (4.1 %)
hemoglobin variants were identified (HbS n= 20,HbC
n= 5,HbE n = 3, Hb Lepore n = 1, HbD n= 1, other un-
common variant n = 3).Interestingly the frequency of
HbS was remarkably high in Africans (19/296, 10 %),
while HbE was confined in Asians(3/78, 4 %) and HbC
was detected in 5/296 (1.7 %)Africans. The most accur-
ate and comprehensive study on epidemiology of hemo-
globinopathies among immigrants in Italy was carried
out from Amato and co-workers [25,26]. They, from
1994 to 2007, performed a screening in secondary
schools and to pregnant couples for hemoglobin variants
in 167,235 residents in Lazio Region (Central Italy).
10,353 of the screened subjects were immigrants, with
an increase during the studied period (2.7 % in 1994 to
9.7 % in 2007).2,484/10,353 immigrants (24 %) had
anomalous hemoglobins, as carriers (n = 2,348, 94.5 %)
or as affected (n = 136, 5.6 %). Among carriers 22.6 %
were β Thal carriers, 48 % suspected α Thal car-
riers,13.8 % HbS carriers, 4 % HbE carriers and 1,8 %
HbC carriers, while 4,3 % were carriers of other rare
hemoglobins. The 136 affected patients mainly include
SCD, β thalassemia major and intermedia, α thalassemia
(hemoglobin H), homozygous HbC, homozygous HbE
and compound heterozygous hemoglobinopathies . The
ethnic groups and the respective more frequently asso-
ciated hemoglobin variants observed both in carriers
and in affected were : African (HbS n= 226, βThal
n = 69, suspected αThal n =321),Asian (suspected αThal
n = 283, βThal n = 92, HbE n= 90,HbS n =3),Central
American (suspected αThal n = 136,HbS n= 55, βThal
n = 46) and Central-East European (suspected αThal
n = 333, βThal n = 280,HbS n= 18,HbE n = 3).
However, hemoglobin carriers and affected patients with
foreign ancestry observed in Italy by the above mentioned
investigations are those of subjects that have immigrated
legally, whereas several unknown immigrants live illegally
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riers and of immigrants affected by hemoglobinopathies is
very large nowadays and likely it will increase in the next
years. Consequently a public health policy and proper
strategies of public health authorities are needed to avoid
the rising frequencies of these disorders due to immigra-
tion, financing and facilitating prevention. Indeed finan-
cing prevention is economically sound when compared to
the public health costs of treatment for a rapidly growing
cumulative number of children with incurable hemoglobi-
nopathies, who survive into adulthood. These preventive
strategies of the public health authorities, that today are
lacking in Italy, should be both prospective and retro-
spective, including three different types of actions : 1°)
information for foreign populations and caregivers; 2°)
healthy carriers detection among immigrants (screening
programs); 3°) Counseling and prenatal diagnosis for
healthy carriers and at-risk immigrant couples[16].
Information is the first step of prevention, and efforts
should be made to reach each foreign groups, promoting
healthy education programs. Notices on the hemoglobi-
nopathies, translated in foreign languages and illustrated
with figurative explanations, should be given by a phys-
ician who explains what they are and how they are
prevented. This information have to provide knowledge,
not anxiety or stigmatization, and needs to be adopted
to the different cultures, paying attention to make clear
that being a carrier is not a disease and that when a car-
rier is diagnosed family analysis is requested. At this
regard, educational pre-matrimonial courses as well as
scholastic information to adolescent pupils and 25 %
possible recurrence risk can allow them to limit family
size. In the same way, post academic courses on hemo-
globinopathies should be organized for caregivers (gen-
eral practitioners, pediatricians, obstetricians, midwifes)
in order to improve their specific knowledge and their
ability of communication with different cultures. x Pre-
vention of a recessive genetic diseases, as the hemoglobi-
nopathies, is usually associated with the concept of
screening of healthy carriers by means of laboratory
investigations. In the past the simple visual tube osmotic
test and simple hemoglobin electrophoresis were sys-
tematically used as first step, while today separation of
hemoglobin fractions on High Performance Liquid
Chromatography (HPLC) is preferred. Molecular ana-
lysis, even if expensive and troublesome, must be always
performed for prenatal diagnosis because it is essential
for primary prevention. Indeed, a large and heterogeneous
number of molecular mutations has been described for
each hemoglobin variant [11,16].They are regionally/area
specific (Mediterranean, Indian Asian, Southeast Asian,
sub-Saharan Africa), and each region or area have a com-
moner but limited number of mutations together with a
very large number of rare mutations that are associatedwith profound phenotypic diversity, not all the defects
being equally severe. It is the case, for example, of the
interaction HbE-βthalassemia in which patients with simi-
lar βthalassemia mutations may have different phenotypes
(some with transfusions dependent anemia and other
without the need of transfusions), or of the co-inheritance
of αThal and βThal genes that leads to a less severe unbal-
ancing in α/β chains ratio, or of the HbH disease and of
SCD that have remarkable phenotypic heterogeneity
related to its underlying molecular defect. Thus immi-
grants, who have a large number of hemoglobin molecular
mutations mirror of their ethnic diversity, considerably in-
crease the complexity of hemoglobinopathies because the
wide range of possible interactions and combinations,
each with a different phenotype, according to their genetic
variability.
School screening with appropriate information and
follow-up of discovered carriers is probably the most ef-
fective intervention for prospective primary prevention,
because sooner carriers are detected and informed,
better it is. The same is the case of an immigrant occa-
sionally found affected by microcytic hypochromic
anemia but without iron deficiency, especially whether
he belongs to ethnic groups with elevated risk for hemo-
globinopathies. Other kinds of healthy carrier’s screening
should be before marriage(some carriers can avoid risk
of hemoglobinopathies selecting a non carrier partner),
before conception (a preconception screening is recom-
mended in all at risk couples), during early pregnancy
(early prenatal diagnosis in a at-risk couples should be
followed by a selective abortion or by a conscious
acceptance of a sick child),in foreign groups where con-
sanguineous marriages are common and generally in
each immigrant population (this global approach will be
possible only after intense programs of information in
ethnic minorities).At this regard, a programmatic
approach is needed in order not to lose undiagnosed
couples at risk. This approach would be offering a car-
rier screening at the first pregnancy control by adding
HPLC to the Rhesus and infectious diseases screening
which is performed in most European countries and
which should be easily accepted in virtually all the
pregnancies.
Finally, a neonatal screening, that places ethical and
multicultural-counseling problems (abortion for medical
reasons, reassurance, anti-stigmatization), should be
offered, as a selective testing, for : 1°) babies of foreign
known carriers of a hemoglobin variant; 2°) babies of im-
migrant parents from an ethnic risk group;3°) babies of
at-risk couples with a previous affected child. In Italy,
where there is a well developed program for screening at
birth for other inherited diseases(phenilketonuria,
hypothyroidism, etc.),this hemoglobin screening might
be easily added in all immigrant newborns as an
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ventive action of newborn screening for hemoglobinopa-
thies is the incidental detection of babies with clinically
insignificant but genetically significant heterozygosity for
a variant hemoglobin. In this case it is mandatory to
offer educational information and hemoglobin testing
both to parents and to whole family. Another important
goal of the detection of affected babies by means of neo-
natal hemoglobinopathy screening is to offer a better
management and care from early infancy, reducing
morbidity and mortality. Regarding SCD, such better
management and care include some vaccinations (against
Streptococcus Pneumonia, Haemophilus Influenza type b,
meningococcus),administration of prophylactic penicillin,
trans-cranial Doppler screening to predict stroke, parental
education and support (counseling) as well as transfusions
when indicated. In all the other clinically relevant hemo-
globinopathies (β thalassemia major, hemoglobin H, com-
bined hemoglobins, etc.)an early diagnosis by neonatal
screening enables appropriate blood transfusion regime, ad-
equate iron chelation therapy and narrow transplantation.
Counseling for both healthy carriers and at-risk couples
is the last phase of prevention, and cultural elements have
to be considered when it is given to individuals with differ-
ent ethnic origin. The fundamental approaches to multi-
cultural counseling are based on : 1°) reassurance (being
carries is not an illness, carriers will no develop the disease
later, being a carrier is a vantage against malaria); 2°) anti-
stigmatization (each individual, not only foreigners, can be
healthy carrier of hereditary diseases and that can be also
the case of either the caregivers or the counselors, abor-
tion for medical reasons is not an immoral and ethically
blamable action); 3°) advantage of knowledge (known to
have a recessive trait can allow pre-marital partner choice,
pre-conception prevention of severe affected children in
at-risk couples, unnecessary iron therapy in carriers). In
addition, counseling provides information regarding the
mode of inheritance of hemoglobinopathies, the genetic
risk of having affected children and the natural history of
hemoglobinopathies, including also their management,
care and prevention.
In conclusion, actually Italy is confronting with massive
migration movements from developing countries where
hemoglobinopathies are widespread. Analogously to other
developed countries, this migratory wave is causing a
larger diffusion and a changing spectrum in the epidemi-
ology of hemoglobinopathies, constituting an emerging
and significant public health problem. In the last years
public health authorities of western-northern European
and northern American countries have started preventive
programs regarding hemoglobinopathies in immigrant
populations, whereas in Italy public programs of this kind
are yet lacking and the majority of caregivers are yet not
aware of this problem due to growing immigration .Therefore, efforts have to be made, offering well organized
preventive actions of public health policy. These have to
be both prospective and retrospective and based on : 1°)
information campaigns and health education programs
both for immigrant groups and caregivers (general practi-
tioners, pediatricians, obstetrics, midwifes); 2°) healthy
carrier detection among immigrants (school screening,
premarital as well as preconception and during early preg-
nancy screening, screening upon laboratory indications,
newborn screening) 3°) proper and multicultural counsel-
ing for healthy carriers and for foreign at-risk couples.Competing interest
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